Bacterionemia matruchotii is an indigenous gram-positive bacteria of dental plaque and plays a significant role in dental calculus formation through its calcifiability (6, 33) . Dental calculus is generally considered to be one of the inflammatory agents in gingival tissues (30) , but the precise role of B. matruchotii on the inflammatory and immunological processes during the dental calculus formation in hosts is not yet clear. In the previous paper (26), we described that B. matruchotii had some effects on macrophages, as the phagocytic function of the reticuloendothelial system in mice was significantly elevated for several days after the injection of this organism, and in vitro bactericidal activity of macrophages obtained from mice injected with B. matruchotii was stronger than that from normal mice. However, possible effects of B. matruchotii on lymphocytes have not been examined. In this paper, we describe experimental results in which a butanol-extracted water-soluble adjuvant (Bu-WSA) extracted from B. matruchotii caused a large increase in the number of antibody-producing cells in marine spleens when injected together with antigens, although whole cells of this organism had scarcely any adjuvant effect on the antibody response in mice. The Bu-WSA described here is a material chemically different from the chemically welldefined water-soluble adjuvant of mycobacterium (1, 17) .
MATERIALS AND METHODS
Bacterial strain. B. matruchotii L2 was cultured in brain heart infusion broth supplemented with 0.2% yeast extract at 370C for 7 days and then harvested, washed with saline, and stored in 40C.
Adjuvant. Bu-WSA was extracted from cells of B. matruchotii L2 in water-saturated n-butanol, digested by Pronase, and subsequently fractionated by gel filtration chromatography (15, 18 ). An aqueous suspension of bacteria (0.25 g/ml) was treated with an equal volume of water-saturated n-butanol at 40C for 15 min. The aqueous phase of the biphasic system formed by centrifugation at 35 ,000 x g for 20 Adjuvant effect of Bu-WSA on the primary PFC response. An i.p. injection of whole cells (1 mg) of B. matruchotii with 108 SRBC into mice provoked a weak adjuvant effect on anti-SRBC PFC responses in their spleens. The PFC numbers in their spleens did not exceed by two or three times those of immune controls during the period of the primary response (data not shown). However, the water-soluble extract (Bu-WSA) of the organism had strong adjuvant effect. After a simultaneous injection with SRBC and Bu-WSA (400 ug), the kinetics of the primary direct and indirect PFC responses in the spleens of mice were examined during a 10-day (Fig. 2) . As controls, the mice receiving only SRBC were included. Bu-WSA showed an effect during the period of days 1 to 3 after the immunization. On day 2, the PFC number of Bu-WSA-injected mice was 10 times greater than that of controls. The direct PFC response reached a peak on day 4, but at that time and thereafter, no adjuvant effect of Bu-WSA could be observed. In addition, no adjuvant effect of Bu-WSA was seen on the primary indirect PFC response on days 7 and 10 after immunization. the numbers of direct PFC in these mice were up to 13-fold higher than those of immune controls (Fig. 3) .
Relation between timing of Bu-WSA injection and its adjuvant effect on anti-SRBC PFC response. The relation between timing of the injection of Bu-WSA and that of SRBC was found to be important for the adjuvant effect of Bu-WSA on the primary response.
Groups of mice were injected with 400,ug of Bu-WSA at varying times either before or after the immunization with 108 SRBC. The PFC numbers in the spleens of these mice were determined 48 h after the immunization and compared with those in control mice which received SRBC alone. As shown in Fig. 4 , differences in the times of injection of Bu-WSA affected significantly its adjuvant effect. Simultaneous injection with SRBC and Bu-WSA resulted in the greatest effect. The adjuvant effect of Bu-WSA decreased as the time between SRBC and Bu-WSA injections was increased. The anomalous result when Bu-WSA was injected 7 days before SRBC injection could not be explained, but very similar effects after the injection of bacterial polysaccharide adjuvants were described by Behling and Nowotny (4).
Antigenic doses affecting adjuvant effect of Bu-WSA on anti-SRBC PFC response. Groups of mice were injected with 2 x 105, 2 x 107, or 2 x 109 SRBC with or without 400 jig of Bu-WSA, and 2 days later, PFC numbers in their spleens were assessed. As shown in Table  1 , the greater the dose of antigen that was administered, the better the adjuvant effect of the Bu-WSA.
Effect of Bu-WSA on carrier-specific T cells helping anti-TNP PFC response. To examine whether the adjuvant effect of Bu-WSA is involved in the generation or activation of helper thymus-derived (T) lymphocytes, the following experiment was carried out. Groups of mice were primed with 108 SRBC alone or 108 SRBC and 400 ,ug of Bu-WSA together. As controls, unprimed mice and Bu-WSA-injected mice were included. Ten days later, all the mice were immunized with 108 TNP SRBC. Forty-eight hours after the immunization, they were sacrificed, and anti-TNP PFC responses in their spleens were assessed. As shown in Table 2 Bu-WSA may be caused partially via the direct activation of antibody-producing B lymphocytes without the help of T lymphocytes.
DISCUSSION
Many kinds of microorganisms and their components (19) , including Mycobacterium (1, 7, 14, 17) , Corynebacterium parvum (Propionibacterium acnes) (9, 10, 21, 34, 35) , Bordetella (12, 20) , Klebsiella (24) , and other gram-negative bacteria, have adjuvant effects. Some kinds of oral microorganisms, such as Veillonella, Fusobacterium, Bacteroides, and Actinomycetes, are also known to have adjuvant effects on antibody responses (27) , and the adjuvant effects of these oral microorganisms are presumed to play some role in the pathogeneses of periodontal diseases (8) .
The microorganism B. matrichotii is capable of stimulating phagocytic function of the reticuloendothelial system and increasing bactericidal activity of macrophages in mice (26) . However, previous or simultaneous injections of these organisms with SRBC as an antigen into mice elicit hardly any adjuvant effect on the antibody-forming cell response in their spleens. This finding does not indicate, however, that these organisms contain no immunologically active substances. Indeed, we demonstrated that a water-soluble extract (Bu-WSA) prepared from the organism according to the method of Morrison and Leive (18) had a significant adjuvant effect when injected with SRBC to mice. The effect of Bu-WSA was observed only on early events in the direct anti-SRBC PFC response in the spleen of mice (Fig. 2) . Small amounts (10 or 20 Atg) of bacterial lipopolysaccharide (22, 25) and capsular polysaccharide of Klebsiellapneumoniae (24) are effective enough to induce in vivo adjuvant action in mice, but a relatively large amount (over 100 gg) of Bu-WSA was necessary to evoke the prominent effect (Fig. 3) . Adjuvant effect of Bu-WSA was more sustained in the mice immunized with higher doses of the antigen (Table 1) . Simultaneous injection of the antigen and Bu-WSA was the most effective, but administration of Bu-WSA before or after the immunization could still elicit the adjuvant effect to some extent (Fig. 4) (Fig. 4) . Bu 
